TGFB1 Protein (AA 279-390) (His tag)

Produktnummer ABIN1081005

Produktdetails

Target: TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))

Protein-Typ: Recombinant

Proteineigenschaft: AA 279-390

Spezies: Maus

Quelle: Escherichia coli (E. coli)

Aufreinigungstag / Konjugat: Dieses TGFB1 Protein ist gelabelt mit His tag.

Applikation: SDS-PAGE (SDS), Western Blotting (WB), Immunogen (Imm), Positive Control (PC)

Sequenz: Ala279-Ser390

Produktmerkmale: Residues: Ala279~Ser390 (Accession # P042028 ), with N-terminal His-Tag.

Reinheit: > 97 %

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

Isoelectric Point:8.4

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-80 °C

Informationen zur Lagerung: Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Haltbarkeit: 12 months

Referenzen

Zhu, Yang, Peng, Yu, Hao: "Exosomal miR-532-5p from bone marrow mesenchymal stem cells reduce intervertebral disc degeneration by targeting RASSF5." in: Experimental cell research, Vol. 393, Issue 2, pp. 112109, (2020) (PubMed).

Zhao, Meng, Zhang, Li, Zhu, Zhang, Wang, Gao: "Astaxanthin ameliorates renal interstitial fibrosis and peritubular capillary rarefaction in unilateral ureteral obstruction." in: Molecular medicine reports, Vol. 19, Issue 4, pp. 3168-3178, (2019) (PubMed).

Sun, Xu, Chen, Qu, Sun, Song, Yuan, Yao: "Pioglitazone attenuates kidney fibrosis via miR-21-5p modulation." in: Life sciences, Vol. 232, pp. 116609, (2019) (PubMed).

Antigendetails

Target: TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))

Andere Bezeichnung: Transforming Growth Factor Beta 1 (TGFB1 Produkte)

Synonyme: CED Protein, DPD1 Protein, LAP Protein, TGFB Protein, TGFbeta Protein, TGF-beta Protein, TGF-BETA-1 Protein, TGF-beta5 Protein, ced Protein, dpd1 Protein, lap Protein, tgf-beta Protein, tgfb Protein, tgfb5 Protein, tgfbeta Protein, TGF-beta1 Protein, TGFbeta1 Protein, Tgfb Protein, Tgfb-1 Protein, ai39657 Protein, tgfb1 Protein, wu:fb13a07 Protein, xx:ai39657 Protein, TGFB1 Protein, csd Protein, cdb1 Protein, cdg2 Protein, csd1 Protein, csd2 Protein, csd3 Protein, ebmd Protein, lcd1 Protein, bigh3 Protein, cdgg1 Protein, betaig-h3 Protein, TGFB4 Protein, transforming growth factor beta 1 Protein, transforming growth factor beta-1 Protein, transforming growth factor beta 1 L homeolog Protein, transforming growth factor, beta 1 Protein, transforming growth factor, beta 1a Protein, transforming growth factor beta induced L homeolog Protein, TGFB1 Protein, Tgfb1 Protein, tgfb1.L Protein, tgfb1a Protein, tgfbi.L Protein

Hintergrund: TGF-B1, CED, DPD1, LAP, Camurati-Engelmann Disease, Latency-associated peptide

Molekulargewicht: 15 kDa

Pathways: EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints